Surveillance and vaccination coverage of measles and rubella in Northern Italy

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 1, 2015, Pages 206-213

  Amendola, Antonella ^a,d   Bubba, Laura ^a   Piralla, Antonio ^b   Binda, Sandro ^a   Piatti, Alessandra ^c   Pariani, Elena ^a,d   Ranghiero, Alberto ^a   Premoli, Marta ^b   Pellegrinelli, Laura ^a   Coppola, Liliana ^c   Gramegna, Maria ^c   Baldanti, Fausto ^b   Zanetti, Alessandro ^a,d  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c Directorate General for Health   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Epidemiology; Measles; Measles and rubella integrated surveillance; MMR vaccine; Phylogeny; Rubella; Vaccine coverage

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ADULT; AGED; CHILD; CLASSIFICATION; DISEASE ERADICATION; DISEASE NOTIFICATION; DNA SEQUENCE; EPIDEMIC; EPIDEMIOLOGICAL MONITORING; FEMALE; GENETICS; GENOTYPE; HEALTH CARE POLICY; HUMAN; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; ITALY; MALE; MEASLES; MEASLES VIRUS; MIDDLE AGED; PRESCHOOL CHILD; PREVALENCE; RETROSPECTIVE STUDY; RUBELLA; STATISTICS AND NUMERICAL DATA; UTILIZATION; VACCINATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE ERADICATION; DISEASE NOTIFICATION; DISEASE OUTBREAKS; EPIDEMIOLOGICAL MONITORING; FEMALE; GENOTYPE; HEALTH POLICY; HUMANS; INFANT; ITALY; MALE; MEASLES; MEASLES VIRUS; MEASLES-MUMPS-RUBELLA VACCINE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RUBELLA; SEQUENCE ANALYSIS, DNA; VACCINATION; YOUNG ADULT;

EID: 84949124275     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.35865     Document Type: Conference Paper

References (26)

1. World Health Organization (WHO). Global measles and rubella strategic plan: 2012-2020; WHO Library Cataloguing-in-Publication Data, 2012. Available from: http://www.who.int/immunization/newsroom/Measles-Rubella-StrategicPlan-2012-2020.pdf (Last access: 06/26/2014).
2. World Health Organization (WHO). Vaccine-preventable disease monitoring system, 2010 global summary. Available from: http://whqlibdoc.who.int/hq/2010/WHO-IVB-2010-eng.pdf (Last access: 06/26/2014).
3. Williams JR, Manfredi P, Butler A, Ciofi degli Atti ML, Salmaso S. Heterogeneity in regional notification patterns and its impact on aggregate national case notification data: the example of measles in Italy. BMC Public Health 2003; 18:3-23; PMID:12871599
4. European Center for Disease Control (ECDC). Latest surveillance data; http://www.ecdc.europa. eu/en/healthtopics/measles/epidemiological-data/Pages/measles-past12months.aspx, update 03-28-2014 (Last access: 06/26/2014).
5. Istituto superiore di Sanità (ISS) and CNESPS. Morbillo&rosolia news; monthly report no4; April 2014, https://www.iss.it/site/rmi/morbillo/ (Last access: 06/26/2014).
6. Muscat M, Shefer A, Ben Mamou M, Spataru R, Jankovic D, Deshevoy S, Butler R, Pfeifer D. The state of measles and rubella in the WHO European Region, 2013. Clin Microbiol Infect 2014; 20(Suppl 5):12-8; PMID:24520948; http://dx.doi.org/10.1111/1469-0691.12584
7. Italian Ministry of Health. Lettera circolare del 20 aprile 2007. Piano nazionale di eliminazione del morbillo e della rosolia congenita: istituzione di un sistema di sorveglianza speciale per morbillo Available from: http://www.epicentro.iss.it/focus/morbillo/pdf/sorveglianza-speciale-morbillo.pdf (Last access: 06/26/2014).
8. Italian Ministry of Health. Piano nazionale per l'eliminazione del morbillo e della rosolia congenita (PNEMoRc) 2010-2015. 2011, Available from: http://www.salute.gov.it/imgs /C-17-pubblicazioni-1519-allegato.pdf (Last access: 06/26/2014)
9. Italian Ministry of Health. Istituzione di un Sistema integrato per il morbillo e la rosolia alla luce del nuovo Piano Nazionale di Eliminazione del morbillo e della rosolia congenita 2010-2015. Available from: http://www.fimproma.org/index.php?option=com-k2&view=item&id=147:ministero-della-salute-istituzione-di-un-sistema-di-sorveglianza-integrato-peril-morbillo-e-la-rosolia-alla-luce-del-nuovo-pianonazionale-di-eliminazione-del-morbillo-e-della-rosolia-congenita-2010-2015&Itemid=174 2013. (Last access: 06/26/2014).
10. Directorate General for Health. Regione Lombardia. Istituzione di un sistema di sorveglianza integrato per il morbillo e la rosolia alla luce del nuovo Piano Nazionale di Eliminazione del morbillo e della rosolia congenita 2010-2015. Indicazioni operative; Available from: www.regione.lombardia.it, Milan, 2013 (Last access: 06/26/2014).
11. GenBank. http://www.ncbi.nlm.nih.gov/genbank/(Last access: 06/26/2014).
12. Semba RD, Bloem MW. Measles blindness. Surv Ophthalmol 2004; 49:243-55; PMID:14998696; http://dx.doi.org/10.1016/j.survophthal.2003.12.005
13. th edition, second printing, 2012, CDC
14. th edition, 2012, CDC
15. th edition, second printing, 2012, CDC
16. European Center for Disease Control (ECDC) technical report: Review of outbreaks and barriers to MMR vaccination coverage among hard-to reach populations in Europe; Venice II Consortium - September 2012
17. Filia A, Bella A, Rota MC, Tavilla A, Magurano F, Baggieri M, et al. Analysis of national measles surveillance data in Italy from October 2010 to December 2011 and priorities for reaching the 2015 measles elimination goal; Euro Surveill. 2013;18 (20): pii=20480. Available on line: http://www.eurosurveillance.org/viewArticle.aspx?Articleld=20480 (Last access: 06/26/2014)
18. Nicholson MS, Leask J. Lessons from an online debate about measles-mumps-rubella (MMR) immunization. Vaccine 2012; 30:3806-12; PMID:22063388; http://dx.doi.org/10.1016/j.vaccine.2011.10.072
19. Uno Y, Uchiyama T, Kurosawa M, Aleksic B, Ozaki N. The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia. Vaccine 2012; 30:4292-8; PMID:22521285; http://dx.doi.org/10.1016/j.vaccine.2012.01.093
20. Oliveira SA, Siqueira MM, Camacho LAB, Nogueira RM, Spinetti CCJ, Cubel Garcia RCN, Knowles W, Brown DW. The aetiology of maculopapular rash diseases in Niterói, State of Rio de Janeiro, Brazil: implications for measles surveillance. Epidemiol Infect 2001; 127:509-16; PMID:11811885; http://dx.doi.org/10.1017/S0950268801005908
21. Ramsay M, Reacher M, O'Flynn C, Buttery R, Hadden F, Cohen B, Knowles W, Wreghitt T, Brown D. Causes of morbilliform rash in a highly immunised English population. Arch Dis Child 2002; 87:202-6; PMID:12193426; http://dx.doi.org/10.1136/adc.87.3.202
22. Rota JS, Rota PA, Redd SB, Redd SC, Pattamadilok S, Bellini WJ. Genetic analysis of measles viruses isolated in the United States, 1995-1996. J Infect Dis 1998; 177:204-8; PMID:9419189; http://dx.doi.org/10.1086/513825
23. Official Journal of the European (ECDC) Communities. Commission Decision of 19 March 2002 laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council. Available from: http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2002:086:0044:0062:EN:PDF (Last access: 06/26/2014)
24. World Health Organization. Manual for the laboratory diagnosis of measles and rubella virus infection, second edition, WHO/IVB/07.01, 2007. Available from: http://www.who.int/ihr/elibrary/manual-diagn-lab-mea-rub-en.pdf (Last access: 06/26/2014)
25. Hübschen JM, Kremer JR, De Landtsheer S, Muller CP. A multiplex TaqMan PCR assay for the detection of measles and rubella virus. J Virol Methods 2008; 149:246-50; PMID:18353451; http://dx.doi.org/10.1016/j.jviromet.2008.01.032
26. Tran DN, Pham NTK, Tran TTT, Khamrin P, Thongprachum A, Komase K, Hayakawa S, Mizuguchi M, Ushijima H. Phylogenetic analysis of rubella viruses in Vietnam during 2009-2010. J Med Virol 2012; 84:705-10; PMID:22337313; http://dx.doi.org/10.1002/jmv.23199